Talisman Wealth Advisors’s Boston Scientific BSX Stock Holding History

Talisman Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,650	Closed	-$253K	–	105
2025 Q4	$253K	Sell	2,650 -61	-2%	-$5.98K	0.2%	97
2025 Q3	$265K	Sell	2,711 -139	-5%	-$14.4K	0.22%	94
2025 Q2	$306K	Sell	2,850 -61	-2%	-$6.17K	0.28%	80
2025 Q1	$294K	Buy	2,911 +11	+0.4%	+$1.11K	0.3%	76
2024 Q4	$259K	Hold	2,900	–	–	0.27%	85
2024 Q3	$242K	Sell	2,900 -4	-0.1%	-$315	0.25%	94
2024 Q2	$224K	Sell	2,904 -298	-9%	-$21.8K	0.26%	90
2024 Q1	$219K	Buy	+3,202	New	+$206K	0.28%	85

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Talisman Wealth Advisors's BSX Position: Q1 2026 in Review

Talisman Wealth Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,650 shares — an estimated $253K sold.

Talisman Wealth Advisors first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $306K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Talisman Wealth Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Talisman Wealth Advisors sold 2,650 Boston Scientific shares in Q1 2026, an estimated $253K.
Talisman Wealth Advisors first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
Talisman Wealth Advisors's Boston Scientific position peaked at $306K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Talisman Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.